The latest price target for Exelixis (NASDAQ:EXEL) was reported by Barclays on April 20, 2026. The analyst firm set a price target for $45.00 expecting EXEL to rise to within 12 months (a possible 1.96% upside). 48 analyst firms have reported ratings in the last year.

The latest analyst rating for Exelixis (NASDAQ:EXEL) was provided by Barclays, and Exelixis maintained their equal-weight rating.

The last upgrade for Exelixis Inc happened on October 21, 2025 when Leerink Partners raised their price target to $48. Leerink Partners previously had a market perform for Exelixis Inc.

The last downgrade for Exelixis Inc happened on January 8, 2026 when Morgan Stanley changed their price target from $45 to $48 for Exelixis Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Exelixis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Exelixis was filed on April 20, 2026 so you should expect the next rating to be made available sometime around April 20, 2027.

While ratings are subjective and will change, the latest Exelixis (EXEL) rating was a maintained with a price target of $44.00 to $45.00. The current price Exelixis (EXEL) is trading at is $44.14, which is within the analyst’s predicted range.